Cargando…

Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial

BACKGROUND: Preclinical studies indicate that the enzyme cyclooxygenase 2 plays an important role in ultraviolet-induced skin cancers. We evaluated the efficacy and safety of celecoxib, a cyclooxygenase 2 inhibitor, as a chemopreventive agent for actinic keratoses, the premalignant precursor of nonm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elmets, Craig A., Viner, Jaye L., Pentland, Alice P., Cantrell, Wendy, Lin, Hui-Yi, Bailey, Howard, Kang, Sewon, Linden, Kenneth G., Heffernan, Michael, Duvic, Madeleine, Richmond, Ellen, Elewski, Boni E., Umar, Asad, Bell, Walter, Gordon, Gary B.
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001966/ https://www.ncbi.nlm.nih.gov/pubmed/21115882 http://dx.doi.org/10.1093/jnci/djq442

Ejemplares similares

The Challenge of Melanoma Chemoprevention
por: Elmets, Craig A., et al.
Publicado: (2022)

No Chemopreventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Nonmelanoma Skin Cancer: Evidence from Meta-Analysis
por: Zhang, Bo, et al.
Publicado: (2014)

Nonmelanoma Skin Cancer
por: Samarasinghe, Venura, et al.
Publicado: (2012)

Nonmelanoma Skin Cancer on the Rise
por: Wollina, Uwe
Publicado: (2012)

CLINICOPATHOLOGICAL EVALUATION OF NONMELANOMA SKIN CANCER
por: Adinarayan, Manjula, et al.
Publicado: (2011)

Targeted Therapy in Nonmelanoma Skin Cancers
por: Spallone, Giulia, et al.
Publicado: (2011)

Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model
por: Woditschka, Stephan, et al.
Publicado: (2008)

Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)
por: Reginster, Jean-Yves, et al.
Publicado: (2017)

NONMELANOMA SKIN CANCER IN INDIA: CURRENT SCENARIO
por: Panda, Saumya
Publicado: (2010)

Botanical Agents for the Treatment of Nonmelanoma Skin Cancer
por: Millsop, Jillian W., et al.
Publicado: (2013)

An estimation of the prevalence of nonmelanoma skin cancer in the U.S.
por: Perera, Eshini, et al.
Publicado: (2013)

The Danish Nonmelanoma Skin Cancer Dermatology Database
por: Lamberg, Anna Lei, et al.
Publicado: (2016)

Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality
por: Elewski, Boni, et al.
Publicado: (2005)

The Value of Mohs Surgery for the Treatment of Nonmelanoma Skin Cancers
por: Alcalay, Joseph
Publicado: (2012)

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
por: Masoumi, K. C., et al.
Publicado: (2011)

Novel Medical Strategies Combating Nonmelanoma Skin Cancer
por: Bhandari, Prasan R, et al.
Publicado: (2014)

Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
por: Latteri, Saverio, et al.
Publicado: (2018)

Nonmelanoma skin cancer in women [Image: see text]
por: Heaton, H., et al.
Publicado: (2018)

Nonmelanoma Skin Cancer with Skull Infiltration and Cranial Involvement
por: Wollina, Uwe, et al.
Publicado: (2019)

Herpes vegetans on the shoulder mimicking nonmelanoma skin cancer
por: Ho, Bao Vincent K., et al.
Publicado: (2022)

Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis
por: Essex, Margaret Noyes, et al.
Publicado: (2014)

Teledermatology: From Prevention to Diagnosis of Nonmelanoma and Melanoma Skin Cancer
por: Fabbrocini, G., et al.
Publicado: (2011)

Validation of claims data algorithms to identify nonmelanoma skin cancer
por: Eide, Melody J., et al.
Publicado: (2012)

Sentinel Lymph Node Biopsy in Nonmelanoma Skin Cancer Patients
por: Matthey-Giè, Marie-Laure, et al.
Publicado: (2013)

Nonmelanoma skin cancer in Saudi Arabia: single center experience
por: AlSalman, Sarah Abdullah, et al.
Publicado: (2018)

Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients
por: Ghahartars, Mehdi, et al.
Publicado: (2018)

Sex‐specific differences in patients with nonmelanoma skin cancer of the pinna
por: Moser, Ulrich, et al.
Publicado: (2020)

Sam68 is required for the growth and survival of nonmelanoma skin cancer
por: Fu, Kai, et al.
Publicado: (2019)

Brunsting-Perry Pemphigoid as Differential Diagnosis of Nonmelanoma Skin Cancer
por: Eichhoff, Gerhard
Publicado: (2019)

Nonmelanoma Skin Cancers: Embryologically Relevant Sites and UV Exposure
por: Nicoletti, Giovanni, et al.
Publicado: (2020)

Nonmelanoma Skin Cancer in COVID-19 Era: The Foggia Experience
por: Lembo, Fedele, et al.
Publicado: (2022)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

Site-specific occurrence of nonmelanoma skin cancers in patients with cutaneous melanoma
por: Neale, R E, et al.
Publicado: (2005)

Nonmelanoma skin cancer in the Federal State of Saarland, Germany, 1995–1999
por: Stang, A, et al.
Publicado: (2003)

Novel treatment options for nonmelanoma skin cancer: focus on electronic brachytherapy
por: Kasper, Michael E, et al.
Publicado: (2015)

The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors
por: Campione, Elena, et al.
Publicado: (2015)

Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation
por: Gräger, Nikolai, et al.
Publicado: (2019)

Aberrant expression and high-frequency mutations of SHARPIN in nonmelanoma skin cancer
por: Zheng, Yan, et al.
Publicado: (2019)

Density of Langerhans Cells in Nonmelanoma Skin Cancers: A Systematic Review
por: Pogorzelska-Dyrbuś, Joanna, et al.
Publicado: (2020)

The Importance of Screening for Inflammatory Bowel Disease in Patients with Psoriasis and Psoriatic Arthritis
por: Aldana, Isabella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d4pimnmtu29e2hp4t17ulcmc3r